FOI release

User consultation reports

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00853

Received 3 August 2026

Published 14 September 2026

Request

We have interest in receiving all of the user consultation reports, i.e. for all the MAs: PL 40546/0178-0179, PL 00427/5014R, PL 00427/0054 and PL 58839/0070-0071.

Response

See attached

Documents

• 2022_Promazine_Hydrochloride_Protocol_TL__Final report_OK (PL 40546_0178-0179) ARISTO PHARMA GMBH redacted.pdf (2.2 MB)
• Consultation with Target Patient Group (PL 004275014R & PL 004275014) -redacted.pdf (76.6 KB)
• FOI2026_00853 (redacted).pdf (637.0 KB)
• uk-consultation (PL 58839_0070-0071) MHRA redacted.pdf (1.4 MB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.